IL128728A0 - Compositions for reducing host vs. graft reaction - Google Patents

Compositions for reducing host vs. graft reaction

Info

Publication number
IL128728A0
IL128728A0 IL12872897A IL12872897A IL128728A0 IL 128728 A0 IL128728 A0 IL 128728A0 IL 12872897 A IL12872897 A IL 12872897A IL 12872897 A IL12872897 A IL 12872897A IL 128728 A0 IL128728 A0 IL 128728A0
Authority
IL
Israel
Prior art keywords
hsp60
compositions
graft reaction
hvgr
severity
Prior art date
Application number
IL12872897A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of IL128728A0 publication Critical patent/IL128728A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL12872897A 1996-08-30 1997-09-02 Compositions for reducing host vs. graft reaction IL128728A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/706,209 US5993803A (en) 1996-08-30 1996-08-30 Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
PCT/US1997/015294 WO1998008536A2 (en) 1996-08-30 1997-09-02 Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity

Publications (1)

Publication Number Publication Date
IL128728A0 true IL128728A0 (en) 2000-01-31

Family

ID=24836651

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12872897A IL128728A0 (en) 1996-08-30 1997-09-02 Compositions for reducing host vs. graft reaction
IL128728A IL128728A (en) 1996-08-30 1999-02-25 Compositions for reducing host vs. graft reaction

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL128728A IL128728A (en) 1996-08-30 1999-02-25 Compositions for reducing host vs. graft reaction

Country Status (11)

Country Link
US (1) US5993803A (da)
EP (1) EP0921810B1 (da)
JP (1) JP4256474B2 (da)
AT (1) ATE237344T1 (da)
AU (1) AU722576B2 (da)
CA (1) CA2263816C (da)
DE (1) DE69721007T2 (da)
DK (1) DK0921810T3 (da)
ES (1) ES2198594T3 (da)
IL (2) IL128728A0 (da)
WO (1) WO1998008536A2 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9911772D0 (en) * 1999-05-21 1999-07-21 Semmelweis University Of Medic Diagnosis and treatment of atherosclerosis
IL150113A0 (en) * 1999-12-15 2002-12-01 Peptor Ltd Fragments and antagonists of heat shock protein 60
JP2004501061A (ja) * 1999-12-15 2004-01-15 ペプトル・リミテツド 熱ショックタンパク質６０のフラグメントおよびアンタゴニスト
US6812205B2 (en) * 2000-03-15 2004-11-02 The Brigham & Women's Hospital, Inc. Suppression of vascular disorders by mucosal administration of heat shock protein peptides
US6989146B2 (en) * 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
US7608683B2 (en) * 2000-08-09 2009-10-27 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
AU2001282475A1 (en) * 2000-08-25 2002-03-04 Yeda Research And Development Co. Ltd. Methods of treatment or prevention of autoimmune diseases with CpG-containing polynucleotide
AU2002220038A1 (en) 2000-11-01 2002-05-15 Alberto Martini Immunomodulatory peptides derived from heat shock proteins and uses thereof
WO2003063759A2 (en) * 2002-01-31 2003-08-07 Peptor Ltd. Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
AU2003209623A1 (en) * 2002-02-19 2003-09-09 Yeda Research And Development Co. Ltd. Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation
WO2003096967A2 (en) 2002-05-21 2003-11-27 Yeda Research And Development Co. Ltd. Dna vaccines encoding heat shock proteins
US7494812B2 (en) * 2003-04-01 2009-02-24 University Of Southern California Generation of human regulatory T cells by bacterial toxins for the treatment of inflammatory disorders
WO2005048914A2 (en) * 2003-11-24 2005-06-02 Yeda Research & Development Co. Ltd. Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases
AU2005207891B2 (en) * 2004-01-28 2010-04-01 Andromeda Biotech Ltd. Hsp therapy in conjunction with a low antigenicity diet
CU23504A1 (es) 2004-09-24 2010-04-13 Ct Ingenieria Genetica Biotech Péptidos y derivados tipo apl de la hsp60 y composiciones farmacéuticas
EP1835933A4 (en) * 2005-01-04 2015-01-07 Yeda Res & Dev HSP60, HSP60-PEPTIDES AND T-CELL VACCINES FOR IMMUNOMODULATION
WO2013128453A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Regeneration of islet beta cells by hsp60 derived peptides
WO2013128450A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92629A0 (en) * 1989-12-10 1990-08-31 Yeda Res & Dev Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases
EP0503055A1 (en) * 1990-09-06 1992-09-16 Rijksuniversiteit Utrecht Inhibitor of lymphocyte response and immune-related disease
IL114407A0 (en) * 1995-06-30 1995-10-31 Yeda Res & Dev Novel peptides and pharmaceutical compositions comprising them
IL114458A0 (en) * 1995-07-05 1995-11-27 Yeda Res & Dev Therapeutic preparations for treatment of T cell mediated diseases

Also Published As

Publication number Publication date
WO1998008536A3 (en) 1998-05-07
IL128728A (en) 2006-09-05
DE69721007T2 (de) 2004-02-12
AU722576B2 (en) 2000-08-10
DK0921810T3 (da) 2003-07-28
US5993803A (en) 1999-11-30
JP4256474B2 (ja) 2009-04-22
WO1998008536A2 (en) 1998-03-05
ES2198594T3 (es) 2004-02-01
CA2263816A1 (en) 1998-03-05
ATE237344T1 (de) 2003-05-15
CA2263816C (en) 2008-12-30
EP0921810B1 (en) 2003-04-16
JP2001500488A (ja) 2001-01-16
AU4242697A (en) 1998-03-19
EP0921810A2 (en) 1999-06-16
DE69721007D1 (de) 2003-05-22

Similar Documents

Publication Publication Date Title
IL128728A0 (en) Compositions for reducing host vs. graft reaction
AU4721696A (en) An osteogenic device and a method for preparing the device
MY131553A (en) Lyophilized formulation of polyethylene oxide modified proteins with increased self-life
MY118995A (en) Oxygen absorption composition
ES2152248T3 (es) Composiciones de colageno de alta concentracion.
EP1052866A3 (en) High priority and/or emergency overload access control system
AU3506197A (en) Automatic voice/text translation of phone mail messages
AU1179795A (en) Improved immunogenic compositions against human gastrin 17
MX9801293A (es) Receptor multimedia y sistema relacionado.
GB2377122A (en) Voice mail interface
EP2295453A3 (en) An appetite-suppressing peptide, its compositions and use
GB2386125A (en) Tolerizing allografts of pluripotent stem cells
PL311227A1 (en) Poly-1-n-alkenoamines and engine fuel and grease preparations containing them
EP0936825A3 (en) Flexible short message processing and delivery
AU1952597A (en) Combinations, having immunosuppressive effects, containing cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor
WO1997011888A3 (de) Magazin für die fixierung von kleinteilen
NZ312327A (en) Controlling hemipteran insect pests with bacillus thuringiensis
GB2364616A (en) Electronic mail systems
EE9900588A (et) CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral
EP1356818A3 (de) Medikament, insbesondere zur Modulation der Immunantwort bei der Bekämpfung von Viren, Tumoren, Bakterien und Parasiten
TW335356B (en) Permselective membranes and methods for their production
GB9007970D0 (en) Fuel oil compositions
AU1869601A (en) Pharmaceutical compositions comprising trimegestone
AU3111195A (en) Alginate fibres, manufacture and use
AU3845095A (en) Childproof package for active substance patches

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed